Actionable genomic information for accurate diagnosis for metastatic patients with diagnostic ambiguity
Key Attributes
Distinguishes between 50 tumor types
Requires small tumor sample (~300 cells)
Most widely adopted gene expression test
Test results available within 5 business days
(from receipt of specimen and required information)
Most validated gene expression test
100% covered by Medicare
CancerTYPE ID: Mechanism of Action
The Most Important Aspect to Treating Tumors
*NeoTYPE tumor profiles are performed by our contracted reference laboratory, NeoGenomics Laboratories, Inc.
